Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,708 public trials 1,048 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery

NCT00290355

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Edegem, Belgium
  • GSK Investigational Site Ghent, Belgium
  • GSK Investigational Site Leuven, Belgium
View all 62 locations
View Trial Details
Completed

OSI-774 (Erlotinib, Tarceva) in Elderly Patients

NCT00200395

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beth Israel Medical Center New York, United States
  • New York University New York, United States
  • Albert Einstein Cancer Center The Bronx, New York, United States
  • Montefiore Medical Center- The Bronx, New York, United States
View Trial Details
Completed

A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)

NCT00978250

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +21 more
Locations
  • University of California, Davis Davis, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Medical Group South Pasadena, California, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC

NCT02047344

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • UCSF San Francisco, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • John Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

Ponatinib in Advanced NSCLC w/ RET Translocations

NCT01813734

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of California, Irvine Orange, California, United States
  • University of Maryland Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT01667562

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Clinic for Pulmonology, Clinical Center of Serbia Belgrade, Serbia
  • Clinical Center Bezanijska Kosa; Oncology Belgrade, Serbia
  • Institute for pulmonary diseases of Vojvodina Kamenitz, Serbia
  • Clinical Center Nis; Clinic for pulmonary diseases Knez Selo Niš, Serbia
View Trial Details

Related conditions